⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

ConvaTec Group PLC (2CV)

Frankfurt
Currency in EUR
2.8200
-0.0200(-0.70%)
Closed
2CV Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
2.82002.8200
52 wk Range
2.52003.4400
Key Statistics
Edit
Bid/Ask
2.84 / 2.88
Prev. Close
2.84
Open
2.82
Day's Range
2.82-2.82
52 wk Range
2.52-3.44
Volume
1
Average Volume (3m)
301
1-Year Change
8.4%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2CV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
376.5000
Upside
+60.0765%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

ConvaTec Group PLC Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson’s disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Compare 2CV to Peers and Sector

Metrics to compare
2CV
Peers
Sector
Relationship
P/E Ratio
39.7x35.6x−0.7x
PEG Ratio
0.340.990.00
Price/Book
3.7x2.4x2.6x
Price / LTM Sales
2.8x3.3x3.2x
Upside (Analyst Target)
-21.3%46.4%
Fair Value Upside
Unlock9.1%6.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.075
Dividend Yield
2.03%
Industry Median 1.26%
Annualised payout
0.0576
Paid unevenly
5-Years Growth
-
Growth Streak

People Also Watch

658.50
VTYV
+4.86%
3.320
ICAG
+4.40%
129.40
TW
+1.17%
842.50
HWDN
+1.26%

FAQ

What Is the ConvaTec Group (2CV) Stock Price Today?

The ConvaTec Group stock price today is 2.82

What Stock Exchange Does ConvaTec Group Trade On?

ConvaTec Group is listed and trades on the Frankfurt stock exchange.

What Is the Stock Symbol for ConvaTec Group?

The stock symbol for ConvaTec Group is "2CV."

Does ConvaTec Group Pay Dividends? What’s The Current Dividend Yield?

The ConvaTec Group PLC dividend yield is 2.10%.

What Is the ConvaTec Group Market Cap?

As of today, ConvaTec Group market cap is 5.83B.

What is ConvaTec Group Earnings Per Share?

The ConvaTec Group EPS is 0.075.

From a Technical Analysis Perspective, Is 2CV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.